Nuzenio

Tradingview Roiv

Tradingview Roiv entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 11 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Timeline

Thu, 06 Aug 2026 23:20:30 GMTRoivant Sciences Ltd. Stock 12‑Month Price Target Raised to $39.73, Implies 15% Upside - TradingView
Thu, 06 Aug 2026 13:32:11 GMTRoivant Sciences Ltd reports results for the quarter ended June 30 - Earnings Summary - TradingView
Thu, 06 Aug 2026 12:46:30 GMTROIV: Strong cash reserves and major settlement boost, with key product launch on track for September - TradingView
Thu, 06 Aug 2026 12:00:28 GMTROIV: Secured $950M from Moderna, advanced pivotal trials, and prepared for a key product launch - TradingView
Thu, 06 Aug 2026 11:32:20 GMTSwitzerland's Roivant Q1 loss widens - TradingView
Thu, 06 Aug 2026 11:31:03 GMTRoivant Sciences Ltd. 2026: Revenue $1.44M, EPS ($0.26) — 10-Q Summary - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Roiv.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.